Header cover image

U.S. Healthcare Sector Analysis

UpdatedJun 26, 2024
DataAggregated Company Financials
Companies1370
  • 7D0.8%
  • 3M-2.5%
  • 1Y7.9%
  • YTD3.9%

Over the last 7 days, the Healthcare industry has remained flat, although notably Merck gained 3.9%. As for the the longer term, the industry is up 7.9% over the past 12 months. As for the next few years, earnings are expected to grow by 21% per annum.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 26 Jun 2024US$6.2tUS$2.8tUS$62.4b30.3x99.7x2.2x
Fri, 24 May 2024US$6.2tUS$2.8tUS$64.3b30.2x97x2.2x
Sun, 21 Apr 2024US$5.9tUS$2.8tUS$84.6b30.2x70.1x2.1x
Tue, 19 Mar 2024US$6.2tUS$2.8tUS$84.7b31.5x73.4x2.2x
Thu, 15 Feb 2024US$6.1tUS$2.8tUS$82.0b31.1x74.6x2.2x
Sat, 13 Jan 2024US$6.4tUS$2.8tUS$90.8b32.2x70.2x2.3x
Mon, 11 Dec 2023US$6.0tUS$2.8tUS$91.4b29.4x65.2x2.1x
Wed, 08 Nov 2023US$5.8tUS$2.8tUS$86.9b25.8x66.6x2.1x
Fri, 06 Oct 2023US$5.8tUS$2.8tUS$98.3b26.7x59.1x2.1x
Sun, 03 Sep 2023US$6.1tUS$2.8tUS$98.7b27.4x61.9x2.2x
Tue, 01 Aug 2023US$6.1tUS$2.7tUS$115.7b28x52.5x2.2x
Thu, 29 Jun 2023US$6.0tUS$2.7tUS$109.9b26.3x54.2x2.2x
Sat, 27 May 2023US$5.8tUS$2.7tUS$110.5b24.4x52.6x2.1x
Mon, 24 Apr 2023US$6.0tUS$2.5tUS$117.6b24.9x51x2.4x
Wed, 22 Mar 2023US$5.7tUS$2.5tUS$124.2b23.4x45.9x2.3x
Fri, 17 Feb 2023US$5.9tUS$2.5tUS$130.3b24.5x45.1x2.4x
Sun, 15 Jan 2023US$6.1tUS$2.5tUS$135.9b22.9x44.6x2.5x
Tue, 13 Dec 2022US$6.1tUS$2.4tUS$133.7b23.7x45.9x2.5x
Thu, 10 Nov 2022US$5.8tUS$2.4tUS$136.7b22.5x42.2x2.4x
Sat, 08 Oct 2022US$5.5tUS$2.4tUS$155.8b21.4x35.5x2.3x
Mon, 05 Sep 2022US$5.7tUS$2.4tUS$156.6b22.2x36.2x2.4x
Wed, 03 Aug 2022US$6.0tUS$2.6tUS$165.6b24.1x36x2.3x
Fri, 01 Jul 2022US$5.8tUS$2.6tUS$165.9b23.6x34.9x2.2x
Sun, 29 May 2022US$6.0tUS$2.6tUS$165.6b25.5x36.3x2.3x
Tue, 26 Apr 2022US$6.3tUS$2.5tUS$174.7b27.9x35.8x2.5x
Thu, 24 Mar 2022US$6.4tUS$2.5tUS$170.6b28.3x37.3x2.6x
Sat, 19 Feb 2022US$6.1tUS$2.5tUS$166.0b28.7x36.7x2.5x
Mon, 17 Jan 2022US$6.5tUS$2.4tUS$145.0b31.5x44.5x2.7x
Wed, 15 Dec 2021US$6.7tUS$2.4tUS$146.1b31x45.7x2.8x
Fri, 12 Nov 2021US$6.8tUS$2.4tUS$146.6b34.4x46.5x2.8x
Sun, 10 Oct 2021US$6.6tUS$2.3tUS$118.8b34.7x55.2x2.8x
Tue, 07 Sep 2021US$7.0tUS$2.3tUS$119.6b30.1x58.7x3x
Thu, 05 Aug 2021US$6.9tUS$2.3tUS$121.4b32.7x56.6x3x
Price to Earnings Ratio

57.7x


Total Market Cap: US$6.6tTotal Earnings: US$113.6bTotal Revenue: US$2.3tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 53.3x202220232024
Current Industry PE
  • Investors are optimistic on the American Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 100x which is higher than its 3-year average PE of 53.3x.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 18% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market-0.27%
Healthcare0.76%
Healthtech1.97%
Biotech1.97%
Pharma1.71%
Healthcare Services0.45%
Medical Equipment-0.36%
Life Sciences-1.45%
Industry PE
  • Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 44.5x.
    • Analysts are expecting annual earnings growth of 27.6%, which is higher than its past year's earnings growth of 15.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 28% over the next 5 years.
  • This is better than its past earnings growth rate of 15% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 17% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MRK MerckUS$132.923.9%
+US$12.5b		17.3%PE146x
LLY Eli LillyUS$904.611.5%
+US$11.8b		94.7%PE132.7x
ALNY Alnylam PharmaceuticalsUS$240.1556.1%
+US$10.9b		27.2%PS15.2x
GILD Gilead SciencesUS$69.6110.2%
+US$8.0b		-8.4%PE178.8x
AMGN AmgenUS$319.314.4%
+US$7.1b		43.4%PE45.5x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALNY

US$240.15

Alnylam Pharmaceuticals

7D

56.1%

1Y

27.2%

ABBV

US$170.75

AbbVie

7D

-0.4%

1Y

28.8%

TMO

US$556.52

Thermo Fisher Scientific

7D

-2.2%

1Y

9.2%

LLY

US$904.61

Eli Lilly

7D

1.5%

1Y

94.7%

DHR

US$254.14

Danaher

7D

-1.3%

1Y

8.7%

What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Jun 23
What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

MDT

US$80.41

Medtronic

7D

0.8%

1Y

-7.7%

GILD

US$69.61

Gilead Sciences

7D

10.2%

1Y

-8.4%

Gilead Records Positive Phase III Results In HIV

Jun 22

SRPT

US$158.06

Sarepta Therapeutics

7D

34.5%

1Y

48.6%

JNJ

US$147.19

Johnson & Johnson

7D

1.1%

1Y

-9.9%

DXCM

US$110.31

DexCom

7D

-5.4%

1Y

-10.7%

MRK

US$132.92

Merck

7D

3.9%

1Y

17.3%

SYK

US$339.55

Stryker

7D

-2.6%

1Y

13.7%

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19
Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

REGN

US$1,071.19

Regeneron Pharmaceuticals

7D

3.1%

1Y

49.6%

AMGN

US$319.31

Amgen

7D

4.4%

1Y

43.4%

Amgen: You Haven't Seen Anything Yet

Jun 17

RMD

US$183.84

ResMed

7D

-13.4%

1Y

-14.1%

MTD

US$1,426.80

Mettler-Toledo International

7D

-3.7%

1Y

12.2%

Mettler-Toledo: Putting On A Lot Of Weight

May 22